000 01107nam a2200337 a 4500
005 20250918142210.0
008 110610s2009 nyua 001 0 eng
020 _a9781606928431
_cRM245.91
039 9 _a201106150948
_bzaleha
_y06-10-2011
_zbalqis
040 _dUKM
060 _aQV55
_b.G3265 2009 9HUKM
090 _aQV55.G3265 2009 9HUKM
245 0 0 _aGeneric drugs :
_bneeds and issues /
_ceditor, Ryan S. Blanton
260 _aHauppauge, N. Y. :
_bNova Science,
_c2009
300 _a157 p. :
_bill. ;
_c24 cm.
490 1 _aHealth care issues, costs and access series
650 2 _aDrugs, Generic
650 2 _aDrug Industry
_xethics
650 2 _aGovernment Regulation
650 2 _aLegislation, Drug
651 2 _aUnited States
700 1 _aBlanton, Ryan S.
830 0 _aHealth care issues, costs and access series
907 _a.b15057525
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV55.G3265 2009 9HUKM
914 _avtls003468238
990 _aNHR/zaleha
991 _aJabatan Farmasi, PPUKM
998 _ah
_b2011-10-06
_cm
_da
_feng
_gnyu
_y0
_z.b15057525
999 _c490426
_d490426